Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05493254 · ClinicalTrials.gov registry record · NA
Enhancing Smoking Cessation Via Telehealth Options in Primary Care
A NA study of Smoking Cessation, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 672
- Enrollment target
- 1
- Study location
NCT05493254: Recruiting NA study of Smoking Cessation, sponsored by Medical University of South Carolina.
NCT05493254 is a NA study of Smoking Cessation that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 672 participants, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05493254, a NA study of Smoking Cessation, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 672 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about smoking history, motivation to quit, and preferences for medications for quitting smoking. Participants may receive a prescription for a smoking cessation medication as an outcome of the e-visit, if randomized to the e-visit group, but there is no requirement to take any medication. This study consists of questionnaires and breath samples provided at 4 separate time points throughout the study. Participation in this study will take about 24 weeks.
Primary Outcome
Number of participants who utilized smoking cessation treatment since last assessment.
Conditions Studied
Interventions
- BEHAVIORAL Treatment As Usual
- BEHAVIORAL Smoking cessation e-visit
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 672 participants |
| Start Date | 2022-08-31 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05493254 shows while recruiting
NCT05493254 is an interventional study that assigns participants to a tested intervention. The registered 672 participants enrollment target is mid-sized for trials with a published cap, above the 471-participant average among 188 other Smoking Cessation trials with a reported enrollment target (43% higher).
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Treatment As Usual is the first listed.
NCT05493254 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05493254 about?
NCT05493254 is a clinical study titled "Enhancing Smoking Cessation Via Telehealth Options in Primary Care". The purpose of this research study is to evaluate an electronic visit (e-visit) for smoking cessation. Participants will be randomly assigned to receive either the smoking cessation e-visit or not. The e-visit will look similar to an online questionnaire asking about smoking history, motivation to q...
What is the current status of trial NCT05493254?
This trial is currently recruiting. It is a NA study. The enrollment target is 672 participants. The study started on 2022-08-31. Estimated completion is 2026-12-31.
What conditions does trial NCT05493254 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT05493254?
The interventions under investigation include: Treatment As Usual (BEHAVIORAL), Smoking cessation e-visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT05493254?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05493254 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05493254's enrollment target sits among peer trials
672 39th of 188 higher than 150 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452031 · 672 participants · NA
A Dyadic Sleep Health Approach for Persons With Alzheimer's Disease and Caregivers
- NCT06651086 · 672 participants · NA
Hybrid Effectiveness-Implementation Trial of an Executive Functioning Intervention for Children's Mental Health Services
- NCT07184944 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- NCT07185009 · 671 participants · Phase 3
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI